Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors
Article in British Journal of Cancer (September 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in British Journal of Cancer (September 2024)
Article in Ecancermedicalscience (July 2024)
Article in Scientific Reports (March 2024)